http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20132375

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 78
issn 1178-6930
pageRange 67-78
publicationName OncoTargets and Therapy
startingPage 67
bibliographicCitation Maruwge W, D'Arcy P, Folin A, Brnjic S, Wejde J, Davis A, Erlandsson F, Bergh J, Brodin B. Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling. Onco Targets Ther. 2008 Nov 01;1():67–78. PMID: 21127754; PMCID: PMC2994208.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7de61a34a9036293df186b656b9e8066
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6e1f482a8d62cbe83702d485e8e1cbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d0478ca5726e8fd18fd8816f753b5ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5526-1847
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aacde38aa75f7395cc0c283918083a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7deba28db86f8f8dd10c737b2504af4a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c83920b142831dbbcb1beff0a78fa6a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6671-7600
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5feed34b30e9b9d7371c1d69e3eaefaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0af50d1c909c14740dcd2a835c7e312
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0551-7976
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01efa8ad4293565c2862b565579af2ac
date 2008-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2994208
https://pubmed.ncbi.nlm.nih.gov/21127754
https://doi.org/10.2147/ott.s3833
isPartOf https://portal.issn.org/resource/ISSN/1178-6930
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37198
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9105
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9152
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9355
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b972b5d726037ca07d19472a4ac78306

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128902940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128423931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128392536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128346259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128548432

Total number of triples: 54.